ENvue Medical Inc
FEED
5 hedge funds and large institutions have $2.31M invested in ENvue Medical Inc in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
10% less capital invested
Capital invested by funds: $2.58M → $2.31M (-$260K)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$408K |
| 2 |
AFS
Amtrust Financial Services
New York
|
-$30.4K |
| 3 |
Millennium Management
New York
|
-$20.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
FEED Hedge Fund Activity: Q2 2018 in Review
5 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q2 2018, worth a combined $2.31M — down 10% from $2.58M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FEED and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Kennedy Capital Management, adding an estimated $182K. The largest seller was Sabby Management, exiting entirely with an estimated $408K sold.
- 5 institutional investors held ENvue Medical Inc (FEED) as of Q2 2018, down from 6 in Q1 2018.
- Funds reported $2.31M of ENvue Medical Inc stock for Q2 2018, down 10% quarter-over-quarter.
- 0 funds opened new ENvue Medical Inc positions in Q2 2018 and 1 closed out, a net change of -1 holder.
- The largest ENvue Medical Inc buyer in Q2 2018 was Kennedy Capital Management, an estimated $182K added.
- The largest ENvue Medical Inc seller in Q2 2018 was Sabby Management, an estimated $408K sold.
Based on aggregated 13F filings for Q2 2018.